Market Overview

Goldman Sachs: Qiagen Has 'Strategic Appeal,' M&A Potential

Goldman Sachs: Qiagen Has 'Strategic Appeal,' M&A Potential

Small market caps, attractive growth prospects and idiosyncratic product cycles among diagnostics companies can lead to valuation volatility while also creating attractive M&A opportunities.

The Analyst

Goldman Sachs analyst Patrick Donnelly initiated coverage on the diagnostics sector with a Neutral sector view while assigning Qiagen NV (NYSE: QGEN) a Buy rating.

The Thesis

Qiagen is "a premium diagnostics platform with strategic appeal that should benefit as new product cycles continue to drive growth against abating HPV headwinds," Donnelly said in a note. 

The analyst models approximately 7-percent organic growth through 2020, citing a “clear path to an inflection in growth” as the company works off pricing headwinds from HPV diagnostics products.

Donnelly also assigned Qiagen an M&A value of "1," indicating the company may be an attractive takeout candidate given its scale, growth profile and end market breadth.

“We believe it would be an attractive strategic asset for acquirers looking for a growth-accretive transaction,” said Donnelly, adding that the company’s valuation is reasonable relative to its growth profile.

Price Action

At the time of publication, Qiagen shares were trading down 0.78 percent at $34.45. 

Latest Ratings for QGEN

Apr 2020StifelMaintainsHold
Mar 2020CFRAMaintainsHold
Feb 2020CFRAMaintainsHold

View More Analyst Ratings for QGEN
View the Latest Analyst Ratings


Related Articles (QGEN)

View Comments and Join the Discussion!

Posted-In: Diagnostics Goldman Sachs Patrick DonnellyAnalyst Color Biotech Initiation Analyst Ratings General Best of Benzinga

Latest Ratings

TRPWells FargoMaintains73.0
ZNGAWells FargoMaintains12.5
WDCWells FargoMaintains55.0
USACWells FargoMaintains12.0
TPVGWells FargoMaintains11.8
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at